We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

A fabric-based pressure sensor created using triboelectric materials and embroidery.

Keyboard or Controller? New Fabric-Based Sensor Can Control Videogames From Your Sleeve

The new technique scan the surface of molecules, tracking their movement.

New Technique Generates “Movies” of Changing Protein Structures

Enhanced scanning electron microscopy (SEM) image of cancer malignant cells with high magnification of the cells surface

Cancer Cells’ Shapeshifting Ability Reveals New Drug Targets

Cannabinols Show Neuroprotective Properties in Fruit Flies

World's Incomes to Fall By 19% by 2050 Due to Climate Change

Amazonian Butterfly a Result of Two Species Hybridizing 200,000 Years Ago

News

Biogen Idec Acquires Convergence Pharmaceuticals

Company to expand neuropathic pain portfolio with the acquisition.

Aptuit to Divest Two Non-Core Sites

AMRI to purchase Glasgow, UK and West Lafayette, Indiana, U.S.A. sites.

Oxford BioTherapeutics Grants an Exclusive License to Boehringer Ingelheim

License for development and commercialization of antibody products to an oncology target.

BioLineRx Announces Completion of Enrollment in CE Mark Registration Trial of BCM

PRESERVATION I trial completion anticipated in mid-2015.

Solvanix Launched with Start-up Investment from the MRCF

Commercializing a technology to reduce aggregation of fully human antibodies.

FDA approves first-of-kind device to treat obesity

The [US] Food and Drug Administration has approved the Maestro Rechargeable System for certain obese adults, the first weight loss treatment device that targets the nerve pathway between the brain and the stomach that controls feelings of hunger and fullness.

Resverlogix Presents at Biotech Showcase During JP Morgan Week

Donald McCaffrey share developments of the Company's proposed new phase 3 clinical trial BETONMACE.

Synthetic Biology Webinar - Genome Modifications Made Easy

IDT reveals how to overcome the challenges of CRISPR-mediated genome editing.

Vygon Group Expands into Singapore

French group Vygon opens a subsidiary in Singapore, strengthening its presence in Asia-Pacific.

Blood Test for Brain Injury May Not Be Feasible

Complications involving the brain’s unique waste removal system – the existence of which has only recently been brought to light – may thwart efforts to identify biomarkers that detect traumatic brain injury (TBI).

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter